Chapter Six – How do companies decide what products and ...

Even if DCs and their companies permit these countries to buy cheaper generic drugs, the lack of an effective health delivery system in many countries may prevent widespread effective therapy. The cost and complexity of AZT (Azidothymidine) and other therapies limit their uses in poor countries (Lamptey et al. 2002). ................
................